The use of hypofractionated intensity-modulated irradiation in the treatment of glioblastoma multiforme: preliminary results of a prospective trial.
about
Radiation and concomitant chemotherapy for patients with glioblastoma multiformeHypofractionated high-dose irradiation with positron emission tomography data for the treatment of glioblastoma multiforme.Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients.MRI-based treatment planning with electron density information mapped from CT images: a preliminary study.Phase II trial of hypofractionated intensity-modulated radiation therapy combined with temozolomide and bevacizumab for patients with newly diagnosed glioblastoma.Validation and simplification of the Radiation Therapy Oncology Group recursive partitioning analysis classification for glioblastomaRadiotherapy and temozolomide for newly diagnosed glioblastoma and anaplastic astrocytoma: validation of Radiation Therapy Oncology Group-Recursive Partitioning Analysis in the IMRT and temozolomide era.Assessment of therapeutic response and treatment planning for brain tumors using metabolic and physiological MRI.Re-irradiation of recurrent glioblastoma multiforme using 11C-methionine PET/CT/MRI image fusion for hypofractionated stereotactic radiotherapy by intensity modulated radiation therapy.Treatment for glioblastoma multiforme: current guidelines and Canadian practice.Phase I study of hypofractionated intensity modulated radiation therapy with concurrent and adjuvant temozolomide in patients with glioblastoma multiforme.Hypofractionated intensity modulated radiotherapy with temozolomide in newly diagnosed glioblastoma multiformeElderly patients with glioblastoma multiforme treated with concurrent temozolomide and standard- versus abbreviated-course radiotherapy.Comparison of radiation regimens in the treatment of Glioblastoma multiforme: results from a single institution.Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastoma.Standard fractionation intensity modulated radiation therapy (IMRT) of primary and recurrent glioblastoma multiformeModified optimal fractionation for poor prognosis malignant gliomas: an elusive search.Hypofractionated radiotherapy for glioblastoma: strategy for poor-risk patients or hope for the future?The radiosensitivity index predicts for overall survival in glioblastomaNew developments in MRI for target volume delineation in radiotherapy.Photon radiotherapy for the treatment of high-grade gliomas.Palliative treatment of poor prognosis patients with malignant gliomas.New Hypofractionation Radiation Strategies for Glioblastoma.Phase 1/2 Trial of 5-Fraction Stereotactic Radiosurgery With 5-mm Margins With Concurrent and Adjuvant Temozolomide in Newly Diagnosed Supratentorial Glioblastoma: Health-Related Quality of Life Results.Corticospinal tract-sparing intensity-modulated radiotherapy treatment planning.Intensity-modulated fractionated stereotactic radiotherapy with reduced margin for high grade gliomas: dosimetric analysis of sparing optic nerve & chiasm.Hypofractionated radiotherapy with simultaneous integrated boost (SIB) plus temozolomide in good prognosis patients with glioblastoma: a multicenter phase II study by the Brain Study Group of the Italian Association of Radiation Oncology (AIRO).Accelerated intensity-modulated radiotherapy plus temozolomide in patients with glioblastoma: a phase I dose-escalation study (ISIDE-BT-1).Coplanar versus noncoplanar intensity-modulated radiation therapy (IMRT) and volumetric-modulated arc therapy (VMAT) treatment planning for fronto-temporal high-grade glioma.Proton beam therapy with concurrent chemotherapy for glioblastoma multiforme: comparison of nimustine hydrochloride and temozolomide.
P2860
Q26827957-42889EF8-636C-4963-894D-12C4B0587B94Q30834011-881ECBAB-A9EC-46D0-84C6-4147514B0BC3Q33356349-E8493E72-FCD8-45ED-8863-1175BF8766A8Q33368403-0FBCA22E-EE65-4C48-96B0-A5F3D3AF7910Q33419421-3372ADD0-3D2B-427D-A743-E5ED560C7BD7Q33708309-8A7D3E6B-925E-4EE6-8A0B-14CF88E0A597Q33779136-AF296DCB-6D0E-4672-AAD2-FC33FF2BEDACQ33888366-F536CDE7-CB45-47FA-B82F-BA35EB5F9366Q34136061-79041D57-322D-40A3-969E-825962789CE0Q34359402-483ACDDC-6143-4E03-A07E-3BC1B3C00DFAQ34593367-6A5DBC8B-8E92-42BF-9F66-D1DFDBFCD299Q34986417-47339F11-DFA2-4884-9F43-2271D647B4C3Q35043237-71AB0021-0A8D-4623-96D9-1C3E19490443Q35575434-5264AB09-BCB9-4FDA-A927-F50800FCBD35Q35911026-307CD0CD-DAED-4484-BCC4-DACDD2F08683Q35924621-89F60F8A-2186-4832-B48A-4C2CB8FD1793Q36078900-ADD25EE1-1B09-47E2-B48A-5B8FA60CD660Q36365570-217B2B97-2D0E-4CC9-86A2-A74A453C57B2Q36544110-B0E65DC5-1613-466F-988B-2763CE8AD3F4Q36596308-D60F27E7-D323-49C2-8DCE-22D76CC07C9DQ37030808-615FAF45-051B-493F-A231-58D5E6FC1A36Q37038922-AB693DCC-E357-4D61-B895-AEBB0A2BE047Q38666254-D070C602-3227-4580-BA52-6CC7FAE2A34DQ38674157-C7F2178F-F0B1-4D05-B5C0-04E9B44A94A4Q42041284-2F511C41-D4D0-43DA-A69F-3A58DCE71F00Q47157031-7EC5AB48-2BBB-4DB2-934C-2C6B9C973E31Q48114988-CA674A11-7C5E-401A-8D0F-94904A597079Q48409107-62A9C4D1-B321-4B67-AAC5-DFD0DE2D58B7Q48449778-723DF769-0404-40C4-81A5-8B89DBF68746Q54525755-B44A489F-CFF0-4A55-A891-AED47C46473B
P2860
The use of hypofractionated intensity-modulated irradiation in the treatment of glioblastoma multiforme: preliminary results of a prospective trial.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
The use of hypofractionated in ...... esults of a prospective trial.
@ast
The use of hypofractionated in ...... esults of a prospective trial.
@en
type
label
The use of hypofractionated in ...... esults of a prospective trial.
@ast
The use of hypofractionated in ...... esults of a prospective trial.
@en
prefLabel
The use of hypofractionated in ...... esults of a prospective trial.
@ast
The use of hypofractionated in ...... esults of a prospective trial.
@en
P2093
P1476
The use of hypofractionated in ...... esults of a prospective trial.
@en
P2093
Christine Lambert
George Shenouda
Horacio Patrocinio
Khalil Sultanem
Luis Souhami
Richard Leblanc
Robert Corns
William Parker
P304
P356
10.1016/S0360-3016(03)00819-8
P407
P577
2004-01-01T00:00:00Z